Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7952 results

Sort By:

In Vitro Maturation of Human Eggs

Study ID: NCT06633120
Start Date: 2023-02-03
End Date: 2030-08-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

IVM

Sponsor

Colorado Center for Reproductive Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Study ID: NCT05455320
Start Date: 2022-10-13
End Date: 2029-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

810

Intervention / Treatment

Talkqueamab

DARATUMUMAB

Pomalidomide

Dexamethasone

Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

CV CARE: CardioVascular Care in PC Patients

Study ID: NCT06202820
Start Date: 2024-01-18
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

CV Care Program

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Prospective Breast Cancer Biospecimen Collection

Study ID: NCT04074720
Start Date: 2018-05-10
End Date: 2028-08-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Tissue Sample collection

Blood Sample Collection

Rectal Swab

Sponsor

Thomas Jefferson University

Source: clinicaltrials.gov

Share:
Add to list

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

Study ID: NCT05764720
Start Date: 2023-05-14
End Date: 2028-02-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

134

Intervention / Treatment

Daily Adaptive External Beam Radiation Therapy

Sponsor

Varian, a Siemens Healthineers Company

Source: clinicaltrials.gov

Share:
Add to list

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Study ID: NCT05902520
Start Date: 2023-06-19
End Date: 2026-05-19
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

DP CD8 to

DP CD8 TIL KD

Low dose Il-2

Sponsor

AgonOx, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Study ID: NCT04941274
Start Date: 2021-09-29
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

86

Intervention / Treatment

Abemaciclib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study of NX-1607 in Adults With Advanced Malignancies

Study ID: NCT05107674
Start Date: 2021-09-29
End Date: 2028-02-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

345

Intervention / Treatment

NX-1607

Paclitaxel

Sponsor

Nurix Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

Study ID: NCT04670874
Start Date: 2023-08-17
End Date: 2034-01-24
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1250

Intervention / Treatment

Quality-of-Life Assessment

Administration questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Study ID: NCT04164082
Start Date: 2020-03-18
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

161

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Cystoscopy

Gemcitabine Hydrochloride

Magnetic Resonance Imaging

Pembrolizumab

Transurethral Resection of Bladder Tumor

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list